How does empagliflozin reduce cardiovascular mortality
This guide covers refrigeration requirements, temperature stability windows, travel considerations, and signs of compromised medication to help patients safely manage their injectable weight loss therapy
247 Mechanistically, it is unclear how GLP-1-based therapies exert beneficial effects on the cardiovascular system, but studies have suggested that this is achieved by direct (cardiovascular GLP-1R activation) and indirect (promotion of the incretin effect) mechanisms
The accumulation of amphetamines effectively reverses the transporter carrier mechanisms, leading to a massive, non-exocytotic efflux of vesicular dopamine out into the cytosol, where it is subsequently transported into the synaptic cleft (Wimalasena 2011)(see Figure 2 Mechanism B)
Injectable semaglutide (0.5 mg, 1.0 mg weekly) receives FDA approval for type 2 diabetes management in December 2017